Sano Genetics | Competitive Intelligence Profile
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision...
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.
🛍️ Sano Genetics Product and Pricing Intelligence →
📅 Sano Genetics Event Participations →
⚖️ Sano Genetics Regulatory Intelligence →
👔 Sano Genetics Management and Leadership Team →
⚔️ Sano Genetics Alternatives and Competitors →
💼 Sano Genetics Hiring and Layoffs →
🤝 Sano Genetics Partnerships, Clients and Vendors →
📈 Sano Genetics Financial Performance, Fundraising, M&A →
🛍️ Sano Genetics Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- Sano Genetics released Episode 243 of The Genetics Podcast featuring Dr. Cara Altimus, CEO of BD², and Dr. Benjamin Neale, Associate Professor at Harvard Medical School and Massachusetts General Hospital, discussing rare variant discovery.
- Sano Genetics published an article on June 10, 2026, arguing that feasibility models for precision medicine trials should focus on how many patients can be found, confirmed, supported, and enrolled, rather than just counting eligible patients.
- Sano Genetics' LiveWell study shows its CLDI measure identifies liver fibrosis with AUC 0.884, outperforming FIB-4's 0.572.
📅 Sano Genetics Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- Charlotte Guzzo, Founder and COO at Sano Genetics, will speak at Meeting on the Med in Rome to discuss challenges in gene therapy trials and solutions for participant identification and trial readiness.
- Sano Genetics CEO Patrick Short announced that Charlotte Guzzo will present the company's perspective on fixing gene therapy trial failures at the Alliance for Regenerative Medicine's Meeting on the Med.
- Sano Genetics' Charlotte Guzzo presented at the Alliance for Regenerative Medicine Meeting on June 12, 2026, highlighting that patient trust and readiness, not just feasibility, are critical for cell and gene therapy trial enrollment, and that their continuous patient engagement infrastructure enabled over-enrollment in a gene therapy trial by matching patients genetically tested three years earlier.
⚖️ Sano Genetics Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
👔 Sano Genetics Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
Vice President of Neuroscience
[email protected] -
Co-Founder and CEO[email protected]
-
CTO and Cofounder[email protected]
-
Founder and COO[email protected]
⚔️ Sano Genetics Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- Akkure |
- Invitae |
- PreventionGenetics |
- Phase Genomics |
- Arima Genomics |
- 10x Genomics |
- Helix |
- Geneticure |
- Eugene |
- MedySapiens |
- Molecular You |
- SITraN |
- Cellartis |
- Fios Genomics |
- Glasgow Precision Oncology Laboratory |
- Renovacor |
- Eikon Therapeutics |
- Interius BioTherapeutics |
- Dermavant Sciences |
- Metrum Research Group |
- Clovis Oncology
💼 Sano Genetics Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Sano Genetics is hiring a Business Development Manager in the United Kingdom (remote) to build their H2 ‘26 and H1 ‘27 pipeline by generating qualified conversations with enterprise pharma accounts.
🤝 Sano Genetics Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
- Sano Genetics partnered with BioMendics to help people with EB Simplex connect with research opportunities, including a pre-screening questionnaire and clinical trial waiting room.
- Patrick Short from Sano Genetics reported that the Livewell study, funded by Innovate UK and partnered with NHS organizations, significantly beat recruitment expectations by using NHS data to identify patients at risk of liver disease for genetic testing and fibroscan.
📈 Sano Genetics Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
People also viewed
- VSPARTICLE |
- Orbital Materials |
- Callosum |
- Rivan Industries |
- Pareto |
- Softmax |
- Validio |
- Mos |
- Civic Marketplace |
- Prosper |
- Augur |
- Phasecraft
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense